The First Oncology-focused Venture Studio

A Moffitt Cancer Center initiative to accelerate the next wave of cancer innovation in partnership with Decimal.health

Join Our Launch – September 22, 2025
RSVP Here
1
in 2
Americans Will Face a Cancer Diagnosis in Their Lifetime.
2
M+
New Cancer Cases are Expected in the U.S. in 2025 Alone.
44
%
Of Cancer Deaths are Preventable Through Early Detection and Intervention.

About AccelerONC

AccelerOnc Studio is the first venture studio in the United States solely dedicated to oncology innovation. This pioneering initiative is designed to translate the deep clinical, scientific, and technological expertise within health systems—starting with Moffitt—into impactful, scalable solutions for cancer patients worldwide.

AccelerOnc Studio will focus on identifying unmet clinical needs and commercializing intellectual property (IP) generated inside health systems and cancer centers, starting with Moffitt’s own IP. By fostering early-stage ventures rooted in real-world insights from frontline care and research, AccelerOnc aims to radically accelerate the path from innovation to impact in oncology.

AccelerOnc pairs Moffitt Cancer Center's cancer care leadership with Decimal.health's proven venture-building capabilities to turn ideas into impact.

patient photo alt ratio

Where Oncology Innovation Begins

We accelerate bold ideas rooted in real clinical pain points and develop breakthrough solutions based on intellectual property emerging from within these same institutions. From concept to company, we’re building the next generation of oncology ventures that are uniquely designed to make an impact where it matters most.
process graphic 1
“AccelerOnc brings together everything it takes to succeed: A world-class cancer center, visionary talent, groundbreaking IP, and a deep commitment to impact.This is more than innovation, it’s our mission in action. We invite entrepreneurs, partners, and investors to join us.Together, we’ll build the future of cancer care.”
1630346197985
Dr. Patrick Whu
CEO, Moffitt Cancer Center
“With AccelerOnc Studio we're not just advancing science. We're building a future where cancer breakthroughs reach people who need them and faster than ever before.”
john cleveland
John Cleveland, Ph.D.
Executive VP, Chief Scientific Officer, Moffitt Cancer Center
“AccelerOnc venture studio aligns deeply with Moffitt's mission and our long-term financial sustainability. It gives a new way to create value from the incredible innovation happening inside Moffitt every day.”
joanna weiss
Joanna Weiss
Executive VP, Chief Financial Officer, Moffitt Cancer Center
“We're entering a really new and exciting era in medicine, an AI augmented world where data algorithms and digital tools will play a growing role in how we deliver cancer care. As clinicians, we have a responsibility to lead in this shift, not just adapt to it. That's what makes AccelerOnc so powerful. We're designing solutions while deeply embedded in Moffitt's clinical and research ecosystem.”
karen lu
Karen Lu, MD
Executive VP, Physician in Chief, Moffitt Cancer Center
"This is an opportunity for us to bring not only innovations to our patient and other providers and systems or industry partners across the world,  but it's also going to meaningfully contribute to Moffitt financials and financial health."
xavier-avat-profile
Xavier Avat
Executive VP, Chief Business Officer, Moffitt Cancer Center
"The Digital Studio has been invaluable in navigating the complex process of bringing research into the business sphere. They have performed market research, shaped use cases for engagement with potential customers, and handled many of the logistics and networking needed to initiate contacts and move the project forward.”
mark robertson tessi
Mark Robertson Tessi
Assistant Faculty Member, Moffitt Cancer Center

Our Team

We are a global team of bold problem solvers accelerating oncology innovation to prevent and cure cancer. United by relentless resilience, excellence, and innovation, every member is an integral puzzle piece driving our vision forward.

Decimal-Health-Team-Group-Shots-20